News & Insights | Compliance & Legal, Biotech & Pharma

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Healthcare fraud enforcement trends: What to expect under the new administration

GDPR seven years later: Compliance in the pharmaceutical industry

Navigating corporate integrity agreements during M&A integration

Beyond ‘no’: The evolving skillset of today’s compliance officer

DOJ Criminal Division unveils major shifts in white-collar crime enforcement

Challenges and AI solutions for HCP engagement expense auditing

Pharma’s expanding field roles challenge traditional boundaries

Top high-risk areas in pharmaceutical M&A transactions

The ‘3 Fs’ of social media compliance scrutiny

Building compliance from the ground up: Tim Stow’s vision at Galderma

How AI can become a ‘thought partner’ to compliance programs

Compliance Insider Contributor Guidelines

Pharmaceutical industry faces multiple challenges from government programs and regulations

Partners in progress: How Novo Nordisk transformed compliance into strategy

Social media and pharma, a necessary presence riddled with risks

Bridging business and ethics: A pharmaceutical compliance leader’s perspective

A fine balance with health systems’ HCP interactions

Industry examples offer a blueprint for stronger compliance

Compliance and the critical role in business success

Legal and compliance insights from a PAP perspective

Quick Links